Software Verification and Validation Planning to Meet CGMP Requirements

Instructor: John E Lincoln
Product ID: 701694
Training Level: Intermediate
  • Duration: 90 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Oct-2012

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

This Software Verification and Validation training will help you understand and recognize the most common software V&V failings and their fixes. You will learn how to develop and use a repeatable software V&V template for all software validation projects.

Course "Software Verification and Validation Planning to Meet CGMP Requirements" has been pre-approved by RAPS as eligible for up to 1.5 RAC credits towards a participant's RAC recertification upon full completion.

Why Should You Attend:

Software and related hardware design, development, verification and validation is difficult to manage, document and control.

This presentation focuses on the verification and validation planning and execution of software after basic developmental testing and de-bug.  It includes COTS (commercial off-the-shelf)  and growing "cloud"-based software.  A suggested FDA model will be evaluated, implemented, with V&V documentation and test case examples.

The focus will be on the most recent issues the FDA has had in this area, and remediation approaches. Software considered include: 1) In-product, 2) As-product, 3) Production and test, and 4) QMS / 21 CFR Pt. 11.  Field examples, good and bad will be addressed. Evaluation of the chief areas of  FDA concerns will focus on actual and anticipated changes in emphasis based on the changing regulatory climate.

This webinar will provide valuable assistance to all regulated companies in evaluating their existing or anticipated software V&V activities and documentation requirements, especially in light of the changes in the FDA's stance vis a vis industry compliance, past problems, and the growing "cloud" environment.

Areas Covered in the Seminar:

  • Recent industry failures.
  • Tougher FDA Expectations / Requirements.
  • Roles of Verification and Validation.
  • An FDA "Model".
  • A Typical Software V&V Protocol / Test Report.
  • A Brief Overview of 21 CFR Part 11.
  • Legacy, Hybrid, New and ER / ES Systems.
  • Expected Regulatory Deliverables.
  • Complementary Guidelines, e.g., GAMP.

Who Will Benefit:

This information applies to personnel / companies in the Pharmaceutical, Medical Device, Diagnostic, Neutraceutical and Biologics fields. The employees who will benefit include:

  • Senior management
  • Regulatory affairs
  • Quality Assurance
  • Production / QAE
  • Engineering, R&D, and software development and testing teams

All personnel involved in a U.S. FDA-regulated environment.  Especially those involved in new product development with products and equipment that are software driven, companies with quality management / MRP / ERP systems moving toward "paperless" systems, or other regulated medical products activities.

Instructor Profile:

John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 30 years experience in U.S. FDA-regulated industries, 16 years as a full-time consultant. John has worked with companies from start-up o Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on all CGMP subjects. John is a graduate of UCLA.

Follow us :
Seminars by Ex-FDA Officials
Medical Device Summit 2018

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed